Howard Pien

Chairman at Sapience Therapeutics, Inc.

Howard Pien

Howard Pien

Chairman at Sapience Therapeutics, Inc.

Overview
Career Highlights

Sapience Therapeutics, Inc.
Medarex, Inc.
Chiron Corp.

RelSci Relationships

2185

Number of Boards

21

Birthday

1958

Age

61

Contact Data
Trying to get in touch with Howard Pien? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Howard Pien likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Executive Director at DBV Technologies

Relationship likelihood: Strong

Chief Executive Officer at Idera Pharmaceuticals, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Aprea Therapeutics AB

Relationship likelihood: Strong

Chief Executive Officer at Clinical Development Capital LLC

Relationship likelihood: Strong

Co-Founder at ARCH Venture Partners

Relationship likelihood: Strong

Chief Executive Officer at Grail, Inc.

Relationship likelihood: Strong

Founder & Chief Executive Officer at Sapience Therapeutics, Inc.

Relationship likelihood: Strong

Senior Vice President, General Counsel/Company Secretary at Reckitt Benckiser Group Plc

Relationship likelihood: Strong

President & Chief Executive Officer at Immunogen Inc.

Relationship likelihood: Strong

Co-Founder at The Institute for New Economic Thinking, Inc.

Relationship likelihood: Strong

Paths to Howard Pien
Potential Connections via
Relationship Science
You
Howard Pien
Chairman at Sapience Therapeutics, Inc.
Education
BS
Class of 1979

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

MBA

The Tepper School of Business is a private business school located on Carnegie Mellon University’s 140-acre campus in Pittsburgh, Pennsylvania, US. The school consistently ranks highly among the top business schools in the U.S., as well as in a wide range of specializations, such as finance, entrepreneurship, operations management and information technology. The school offers degrees from the undergraduate through doctoral levels, in addition to executive education programs.

BS Civil Enginerring

MIT Sloan School of Management is the business school of the Massachusetts Institute of Technology, in Cambridge, Massachusetts, USA. MIT Sloan offers bachelor's, master's, and doctoral programs, as well as non-degree executive education. Its largest program is its full-time MBA, which is one of the most selective in the world, with students from more than 60 countries every year, and ranked #1 in more subjects than any other MBA program.

Career History
Chairman
Current

Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY.

Advisor, Life Sciences
Current

Warburg Pincus focuses on investments in the following sectors: financial services, healthcare, energy, consumer/manufacturing/industrials and technology, media and telecommunications (TMT). The firm participates in venture capital investments, growth equity investments, spin-outs, LBOs and special situation opportunities. They invest primarily in North America, Europe and Asia.Warburg Pincus' financial services investments primarily focus on the following industries: (1) asset/wealth management (2) banks and depository institutions (3) exchanges (4) financial technology (5) growth companies, developing economies and new markets (6) insurance companies (7) payment and transaction processing companies (8) private banking and (9) specialty and consumer finance. The firm's healthcare investments focus mainly on medical devices, healthcare services, biotechnology, pharmaceuticals and European healthcare. Within the technology, media and telecommunications (TMT) sector, Warburg Pincus targets investments in the following areas: (1) software (2) media, information and Internet (3) financial technology (4) telecommunications (5) business services and (6) systems and semiconductors. The firm's energy investments focus on (1) oil and gas including exploration and production, midstream, refining and oilfield services (2) power generation and transmission (3) alternative energy/renewables and (4) innovative energy technologies.Warburg Pincus takes a long-term perspective and invests in companies across all stages of development, from founding start-ups and furthering growth in developing companies to leading recapitalizations or buy-outs of more mature businesses.

Head of New Product Development
Tenure Unconfirmed

SmithKline Beecham plc is a company focused on pharmaceuticals, biologics, vaccines, and consumer healthcare. It was formed by the merging of Beecham plc and SmithKline Beckman Corporation. It manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions.It's key selling drugs for mental health conditions were Advair, Avodart, Flovent, Augmentin, Lovaza, and Lamictal for the year 2013. Its consumer healthcare division, which earned £5.2 billion in 2013, sells oral healthcare and nutritional products, drinks and over-the-counter medicines, including Sensodyne, Boost and Horlicks. SmithKline Beecham plc is based in Brentford, London.

Boards & Committees
Chairman
Current

Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA.

Member, Compensation Committee
2012 - 2013

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Director
2010 - 2011

Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California.

Director
Prior

The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA.

Director
Prior

UCSF Benioff Children's Hospital Oakland provides healthcare services. It offers child life program, family outreach clinics, hand and microsurgery, parent infant programs, pastoral care, neurosurgery, injury prevention programs and respiratory care services. The company was founded by Bertha Wright in 1912 and is headquartered in Oakland, CA.

Political Donations
$1,000
2004

Senator from North Carolina

$1,000
2000

Former Senator from Utah

$250
1998

President & Chief Executive Officer at Biotechnology Innovation Organization

Investments
Details Hidden

SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Howard Pien. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Howard Pien's profile does not indicate a business or promotional relationship of any kind between RelSci and Howard Pien.